| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected and Quantified |
|---|
| Creation Date | 2006-12-06 15:50:25 UTC |
|---|
| Update Date | 2023-02-21 17:17:07 UTC |
|---|
| HMDB ID | HMDB0005199 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | (R)-Salsolinol |
|---|
| Description | Salsolinol is an endogenous catechol isoquinoline detected in humans. Salsolinol was detected in urine of parkinsonian patients administered with L-DOPA. This finding stimulated the studies on Salsolinol derivatives in the brain, and gave new aspects of the endogenous alkaloids, which had been considered to occur only in plants. In normal non-alcoholic subjects and alcoholics, Salsolinol and O-methylated Salsolinol were found in urine, cerebrospinal fluid and brains. Salsolinol has an asymmetric center at first position and exists as (R)- and (S)enantiomer. The (R)enantiomer of Salsolinol is predominant in urine from healthy volunteers. Only the (R)enantiomers of Salsolinol and N-methylated Salsolinol occur in the human brain, cerebrospinal fluid (CSF) and intraventricular fluid (IVF), and the (S)enantiomers were not detected. (R)salsolinol synthase catalyzes the enantio-selective synthesis of (R)Salsolinol and 1-carboxyl(R)Salsolinol from dopamine with acetaldehyde or pyruvic acid. The N-methylation of (R)salsolinol into N-methylsalsolinol (NMSal) is catalyzed by two N-methyltransferases with different optimum pH, at pH 7.0 and 8.4. NM(R)Salsolinol is enzymatically oxidized into 1,2-dimethyl-6,7-dihydroxyisoquinolinium ion (DMDHIQ+) by an oxidase sensitive to semicarbaside and also non-enzymatically by autoxidation. NM(R)Salsolinol and its precursor, dopamine, were found to occur selectively in the nigro-striatum, whereas (R)Salsolinol distributes uniformly among the brain regions. (PMID 14697894 ). |
|---|
| Structure | InChI=1S/C10H13NO2/c1-6-8-5-10(13)9(12)4-7(8)2-3-11-6/h4-6,11-13H,2-3H2,1H3 |
|---|
| Synonyms | | Value | Source |
|---|
| (+)-(R)-Salsolinol | HMDB | | (+)-Salsolinol | HMDB | | (R)-(+)-Salsolinol | HMDB | | 1-Methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline | HMDB | | Salsolinol, (S)-isomer | HMDB | | 1-Methyl-6,7-dihydroxytetrahydroisoquinoline | HMDB | | Salsolinol hydrobromide | HMDB | | Salsolinol | HMDB | | Salsolinol, (+-)-isomer | HMDB |
|
|---|
| Chemical Formula | C10H13NO2 |
|---|
| Average Molecular Weight | 179.2157 |
|---|
| Monoisotopic Molecular Weight | 179.094628665 |
|---|
| IUPAC Name | 1-methyl-1,2,3,4-tetrahydroisoquinoline-6,7-diol |
|---|
| Traditional Name | (+)-salsolinol |
|---|
| CAS Registry Number | 525-72-4 |
|---|
| SMILES | CC1NCCC2=C1C=C(O)C(O)=C2 |
|---|
| InChI Identifier | InChI=1S/C10H13NO2/c1-6-8-5-10(13)9(12)4-7(8)2-3-11-6/h4-6,11-13H,2-3H2,1H3 |
|---|
| InChI Key | IBRKLUSXDYATLG-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as tetrahydroisoquinolines. These are tetrahydrogenated isoquinoline derivatives. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Tetrahydroisoquinolines |
|---|
| Sub Class | Not Available |
|---|
| Direct Parent | Tetrahydroisoquinolines |
|---|
| Alternative Parents | |
|---|
| Substituents | - Tetrahydroisoquinoline
- 1-hydroxy-2-unsubstituted benzenoid
- Aralkylamine
- Benzenoid
- Azacycle
- Secondary amine
- Secondary aliphatic amine
- Organic nitrogen compound
- Organic oxygen compound
- Organopnictogen compound
- Hydrocarbon derivative
- Organooxygen compound
- Organonitrogen compound
- Amine
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 1.5 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 8.6173 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 5.0 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 194.2 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 456.0 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 253.3 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 80.5 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 149.9 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 37.6 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 268.9 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 230.5 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 649.8 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 577.7 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 50.2 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 635.4 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 159.6 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 174.4 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 572.5 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 489.2 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 267.9 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| (R)-Salsolinol,1TMS,isomer #1 | CC1NCCC2=CC(O)=C(O[Si](C)(C)C)C=C21 | 1878.8 | Semi standard non polar | 33892256 | | (R)-Salsolinol,1TMS,isomer #2 | CC1NCCC2=CC(O[Si](C)(C)C)=C(O)C=C21 | 1873.4 | Semi standard non polar | 33892256 | | (R)-Salsolinol,1TMS,isomer #3 | CC1C2=CC(O)=C(O)C=C2CCN1[Si](C)(C)C | 1993.4 | Semi standard non polar | 33892256 | | (R)-Salsolinol,2TMS,isomer #1 | CC1NCCC2=CC(O[Si](C)(C)C)=C(O[Si](C)(C)C)C=C21 | 1905.1 | Semi standard non polar | 33892256 | | (R)-Salsolinol,2TMS,isomer #2 | CC1C2=CC(O[Si](C)(C)C)=C(O)C=C2CCN1[Si](C)(C)C | 1917.5 | Semi standard non polar | 33892256 | | (R)-Salsolinol,2TMS,isomer #3 | CC1C2=CC(O)=C(O[Si](C)(C)C)C=C2CCN1[Si](C)(C)C | 1921.9 | Semi standard non polar | 33892256 | | (R)-Salsolinol,3TMS,isomer #1 | CC1C2=CC(O[Si](C)(C)C)=C(O[Si](C)(C)C)C=C2CCN1[Si](C)(C)C | 1990.3 | Semi standard non polar | 33892256 | | (R)-Salsolinol,3TMS,isomer #1 | CC1C2=CC(O[Si](C)(C)C)=C(O[Si](C)(C)C)C=C2CCN1[Si](C)(C)C | 1967.4 | Standard non polar | 33892256 | | (R)-Salsolinol,3TMS,isomer #1 | CC1C2=CC(O[Si](C)(C)C)=C(O[Si](C)(C)C)C=C2CCN1[Si](C)(C)C | 2053.2 | Standard polar | 33892256 | | (R)-Salsolinol,1TBDMS,isomer #1 | CC1NCCC2=CC(O)=C(O[Si](C)(C)C(C)(C)C)C=C21 | 2131.8 | Semi standard non polar | 33892256 | | (R)-Salsolinol,1TBDMS,isomer #2 | CC1NCCC2=CC(O[Si](C)(C)C(C)(C)C)=C(O)C=C21 | 2131.9 | Semi standard non polar | 33892256 | | (R)-Salsolinol,1TBDMS,isomer #3 | CC1C2=CC(O)=C(O)C=C2CCN1[Si](C)(C)C(C)(C)C | 2215.9 | Semi standard non polar | 33892256 | | (R)-Salsolinol,2TBDMS,isomer #1 | CC1NCCC2=CC(O[Si](C)(C)C(C)(C)C)=C(O[Si](C)(C)C(C)(C)C)C=C21 | 2375.0 | Semi standard non polar | 33892256 | | (R)-Salsolinol,2TBDMS,isomer #2 | CC1C2=CC(O[Si](C)(C)C(C)(C)C)=C(O)C=C2CCN1[Si](C)(C)C(C)(C)C | 2426.8 | Semi standard non polar | 33892256 | | (R)-Salsolinol,2TBDMS,isomer #3 | CC1C2=CC(O)=C(O[Si](C)(C)C(C)(C)C)C=C2CCN1[Si](C)(C)C(C)(C)C | 2420.0 | Semi standard non polar | 33892256 | | (R)-Salsolinol,3TBDMS,isomer #1 | CC1C2=CC(O[Si](C)(C)C(C)(C)C)=C(O[Si](C)(C)C(C)(C)C)C=C2CCN1[Si](C)(C)C(C)(C)C | 2674.2 | Semi standard non polar | 33892256 | | (R)-Salsolinol,3TBDMS,isomer #1 | CC1C2=CC(O[Si](C)(C)C(C)(C)C)=C(O[Si](C)(C)C(C)(C)C)C=C2CCN1[Si](C)(C)C(C)(C)C | 2659.2 | Standard non polar | 33892256 | | (R)-Salsolinol,3TBDMS,isomer #1 | CC1C2=CC(O[Si](C)(C)C(C)(C)C)=C(O[Si](C)(C)C(C)(C)C)C=C2CCN1[Si](C)(C)C(C)(C)C | 2463.2 | Standard polar | 33892256 |
|
|---|
| Spectra |
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - (R)-Salsolinol GC-MS (Non-derivatized) - 70eV, Positive | splash10-0ik9-0900000000-ea926c78d9164b4155df | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - (R)-Salsolinol GC-MS (2 TMS) - 70eV, Positive | splash10-0ab9-3295000000-9789c284ef49e7af9bff | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - (R)-Salsolinol GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - (R)-Salsolinol LC-ESI-QTOF , positive-QTOF | splash10-01q9-0900000000-2c29348adb1dba658757 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - (R)-Salsolinol LC-ESI-QTOF , positive-QTOF | splash10-01ot-0900000000-a28325af4d693ae8c614 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - (R)-Salsolinol LC-ESI-QTOF , positive-QTOF | splash10-00kb-0900000000-d89b4eb37f9694e3dbb2 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - (R)-Salsolinol LC-ESI-QTOF , positive-QTOF | splash10-014i-0900000000-fd496b1ca2ec080ac77b | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - (R)-Salsolinol LC-ESI-ITFT , positive-QTOF | splash10-03di-0900000000-2894c6730bbdd8586e0d | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - (R)-Salsolinol LC-ESI-ITFT , positive-QTOF | splash10-03di-0900000000-b95a812b67613811248b | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - (R)-Salsolinol LC-ESI-ITFT , positive-QTOF | splash10-03di-0900000000-e65251ff89ea89a15814 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - (R)-Salsolinol LC-ESI-ITFT , positive-QTOF | splash10-03di-0900000000-ce7a81f09123f28c4b24 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - (R)-Salsolinol 15V, Positive-QTOF | splash10-01ot-0900000000-2e943291c5430f91a8ff | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - (R)-Salsolinol 20V, Positive-QTOF | splash10-00kb-0900000000-b73360d52cf5dff31b8d | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - (R)-Salsolinol 10V, Positive-QTOF | splash10-01q9-0900000000-2821f1026dd4b464da9d | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - (R)-Salsolinol 15V, Positive-QTOF | splash10-01ot-0900000000-39e018ed344d997de3b0 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - (R)-Salsolinol 30V, Positive-QTOF | splash10-014i-0900000000-9e8d0f4134ccc42a8296 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - (R)-Salsolinol 20V, Positive-QTOF | splash10-00kb-0900000000-b99cb041281370993301 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - (R)-Salsolinol 10V, Positive-QTOF | splash10-01q9-0900000000-5cd66c681b07ac5f232e | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - (R)-Salsolinol 15V, Positive-QTOF | splash10-01ot-0900000000-24e6da15427270ddc80c | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - (R)-Salsolinol 70V, Positive-QTOF | splash10-03di-0900000000-3755faa761a6e281bf8b | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - (R)-Salsolinol 55V, Positive-QTOF | splash10-03di-0900000000-be13089127e47b801b60 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - (R)-Salsolinol 20V, Positive-QTOF | splash10-00kb-0900000000-d45c2139d9620f895f41 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (R)-Salsolinol 10V, Positive-QTOF | splash10-001i-0900000000-1c070d491bdf6a8f80d3 | 2015-04-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (R)-Salsolinol 20V, Positive-QTOF | splash10-001i-0900000000-7a8e025141a2d1299eb4 | 2015-04-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (R)-Salsolinol 40V, Positive-QTOF | splash10-06y9-3900000000-bed1ede28e58e633dcbe | 2015-04-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (R)-Salsolinol 10V, Negative-QTOF | splash10-004i-0900000000-f913db2f113ff2f73d08 | 2015-04-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (R)-Salsolinol 20V, Negative-QTOF | splash10-004i-0900000000-726420a5901821528a90 | 2015-04-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (R)-Salsolinol 40V, Negative-QTOF | splash10-03dl-5900000000-aaac23c6385c30ec14b5 | 2015-04-25 | Wishart Lab | View Spectrum |
NMR Spectra| Spectrum Type | Description | Deposition Date | Source | View |
|---|
| Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum |
IR Spectra| Spectrum Type | Description | Deposition Date | Source | View |
|---|
| Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M-H]-) | 2023-02-03 | FELIX lab | View Spectrum | | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+H]+) | 2023-02-03 | FELIX lab | View Spectrum | | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+Na]+) | 2023-02-03 | FELIX lab | View Spectrum |
|
|---|
| Biological Properties |
|---|
| Cellular Locations | Not Available |
|---|
| Biospecimen Locations | - Blood
- Cerebrospinal Fluid (CSF)
- Feces
|
|---|
| Tissue Locations | Not Available |
|---|
| Pathways | |
|---|
| Normal Concentrations |
|---|
| |
| Blood | Detected and Quantified | 0.00042 +/- 0.000094 uM | Adult (>18 years old) | Both | Normal | | details | | Blood | Detected and Quantified | 0.0022 +/- 0.0015 uM | Adult (>18 years old) | Both | Normal | | details | | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.005 +/- 0.002 uM | Adult (>18 years old) | Not Specified | Normal | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details |
|
|---|
| Abnormal Concentrations |
|---|
| |
| Blood | Detected and Quantified | 0.0010 +/- 0.00043 uM | Adult (>18 years old) | Both | Hypertension | | details | | Blood | Detected and Quantified | 0.0019 +/- 0.00078 uM | Adult (>18 years old) | Both | After alcohol intake | | details | | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.005 +/- 0.001 uM | Adult (>18 years old) | Not Specified | Parkinson's disease | | details | | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.004 +/- 0.001 uM | Adult (>18 years old) | Not Specified | Multiple System Atrophy (MSA) | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal Cancer | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal cancer | | details |
|
|---|
| Associated Disorders and Diseases |
|---|
| Disease References | | Hypertension |
|---|
- Andrew R, Best SA, Watson DG, Midgley JM, Reid JL, Squire IB: Analysis of biogenic amines in plasma of hypertensive patients and a control group. Neurochem Res. 1993 Nov;18(11):1179-82. [PubMed:8255371 ]
| | Parkinson's disease |
|---|
- Zhang W, Xie Y, Gu J, Ai S, Wang J, Yamamoto K, Jin L: Liquid chromatography with amperometric detection at a nano crystalline Ce-doped lead dioxide film modified electrode for determination of (R)-Salsolinol, (R)-N-methylsalsolinol and monoamine neurotransmitters in Parkinsonian patients' cerebrospinal fluid. Analyst. 2004 Mar;129(3):229-34. Epub 2004 Feb 6. [PubMed:14978525 ]
| | Multiple system atrophy |
|---|
- Naoi M, Maruyama W: Cell death of dopamine neurons in aging and Parkinson's disease. Mech Ageing Dev. 1999 Nov;111(2-3):175-88. [PubMed:10656535 ]
| | Colorectal cancer |
|---|
- Brown DG, Rao S, Weir TL, O'Malia J, Bazan M, Brown RJ, Ryan EP: Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab. 2016 Jun 6;4:11. doi: 10.1186/s40170-016-0151-y. eCollection 2016. [PubMed:27275383 ]
- Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18. [PubMed:25037050 ]
|
|
|---|
| Associated OMIM IDs | |
|---|
| External Links |
|---|
| DrugBank ID | Not Available |
|---|
| Phenol Explorer Compound ID | Not Available |
|---|
| FooDB ID | FDB018047 |
|---|
| KNApSAcK ID | Not Available |
|---|
| Chemspider ID | 49181 |
|---|
| KEGG Compound ID | C09642 |
|---|
| BioCyc ID | Not Available |
|---|
| BiGG ID | Not Available |
|---|
| Wikipedia Link | Not Available |
|---|
| METLIN ID | Not Available |
|---|
| PubChem Compound | 54456 |
|---|
| PDB ID | Not Available |
|---|
| ChEBI ID | 123715 |
|---|
| Food Biomarker Ontology | Not Available |
|---|
| VMH ID | C09642 |
|---|
| MarkerDB ID | Not Available |
|---|
| Good Scents ID | Not Available |
|---|
| References |
|---|
| Synthesis Reference | Kovacs, Odon; Fodor, Gabor. The synthesis of tetrahydroisoquinoline alkaloids under physiological conditions. Chemische Berichte (1951), 84 795-801. |
|---|
| Material Safety Data Sheet (MSDS) | Not Available |
|---|
| General References | - Zhang W, Xie Y, Gu J, Ai S, Wang J, Yamamoto K, Jin L: Liquid chromatography with amperometric detection at a nano crystalline Ce-doped lead dioxide film modified electrode for determination of (R)-Salsolinol, (R)-N-methylsalsolinol and monoamine neurotransmitters in Parkinsonian patients' cerebrospinal fluid. Analyst. 2004 Mar;129(3):229-34. Epub 2004 Feb 6. [PubMed:14978525 ]
- Naoi M, Maruyama W: Cell death of dopamine neurons in aging and Parkinson's disease. Mech Ageing Dev. 1999 Nov;111(2-3):175-88. [PubMed:10656535 ]
- Naoi M, Maruyama W, Nagy GM: Dopamine-derived salsolinol derivatives as endogenous monoamine oxidase inhibitors: occurrence, metabolism and function in human brains. Neurotoxicology. 2004 Jan;25(1-2):193-204. [PubMed:14697894 ]
|
|---|